Medical Condition

dry eye disease

Total Trials

4

Recruiting Now

4

Trial Phases

Phase 2

ClinicalMetric tracks all active clinical trials for dry eye disease sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Trial Phases

Phase 2

Top Sponsors

TRB Chemedica International SA 1 trial

Beijing Tongren Hospital 1 trial

Instituto Grifols, S.A. 1 trial

Alcon Research 1 trial

NCT05865379

Recruiting

Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease

TRB Chemedica International SA

View Trial →

NCT04673643 Phase 2

Recruiting

Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease

Beijing Tongren Hospital

View Trial →

NCT07264517 Phase 2

Recruiting

Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).

Instituto Grifols, S.A.

View Trial →

NCT07238699

Recruiting

An Evaluation of the Safety and Tolerability of Ocular Lubricants

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology